Perceptions | Buprenorphine | Naltrexone | t | df | Mean of the Difference | Cohen’s d | 95% Confidence Interval | p | |||
---|---|---|---|---|---|---|---|---|---|---|---|
n | Mean (SD) | n | Mean (SD) | Lower | Upper | ||||||
MOUD decreases risk of death from opioid overdose | 52 | 4.327 (1.024) | 52 | 3.769 (0.921) | 3.413 | 51 | 0.558 | 0.755 | 0.230 | 0.885 | 0.001* |
MOUD decreases cravings for opioids | 53 | 4.491 (0.869) | 53 | 3.566 (1.118) | 4.474 | 52 | 0.925 | 0.924 | 0.510 | 1.339 | < 0.001* |
MOUD decreases rates of relapse | 50 | 4.200 (1.030) | 50 | 3.840 (0.792) | 2.078 | 49 | 0.360 | 0.392 | 0.012 | 0.708 | 0.043* |
MOUD works well in patients with co-occurring mental health disorders | 50 | 4.220 (0.996) | 50 | 3.780 (0.954) | 2.461 | 49 | 0.440 | 0.451 | 0.081 | 0.799 | 0.017* |
MOUD should be supplemented by mental health counseling | 56 | 4.571 (0.806) | 56 | 4.393 (0.846) | 1.563 | 55 | 0.179 | 0.215 | −0.050 | 0.408 | 0.124 |
MOUD should be supplemented by participation in peer support groups | 57 | 4.298 (0.999) | 57 | 4.193 (1.043) | 0.973 | 56 | 0.105 | 0.103 | −0.111 | 0.322 | 0.335 |
MOUD efficacy is improved by adding mental health counseling | 56 | 4.518 (0.853) | 56 | 4.429 (0.828) | 0.962 | 55 | 0.089 | 0.106 | −0.0979 | 0.2756 | 0.001* |